Even though pharmacy giants like CVS and Walgreens have denied that Wal-Mart’s $4 drug plan has affected sales, Walgreens stock has slumped by 15 percent, and the chain has announced lower-than-expected third quarter earnings.

According to Peter Rost at Brandweek NRX, weaker margins on generic drugs were the reason for the slump. Peter also says that Wal-Mart has “just started wreaking havoc in the drug market. Target and others followed. Nothing will be the same. Watch as the old stalwarts try to keep prices high, until they finally bite the dust.”

Wal-Mart said Sept. 27 it would increase the number of generic medications covered by its plan to 361.

About Cary Byrd

eDrugSearch founder, Cary Byrd, has been called an “e-health innovator” by MarketIntellNow, interviewed by top pharmaceutical industry journalists, invited to Matthew Holt’s Health 2.0 Conference and a Consumer Report's health summit, and highlighted on numerous health blogs.

eDrugSearch.com - Search. Compare. Save.

Leave a Reply

Join Our Free Newsletter

Please enter email id

Get a weekly dose of money-saving tips on your medications, drug side effects alerts, drug interaction warnings, free prescription coupons, late-breaking safety information and much, much more!

Share via
Copy link